Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Research & Development: 2014-2025

Historic Research & Development for Aytu Biopharma (AYTU) over the last 12 years, with Jun 2025 value amounting to $1.3 million.

  • Aytu Biopharma's Research & Development fell 79.27% to $216,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 million, marking a year-over-year decrease of 52.11%. This contributed to the annual value of $1.3 million for FY2025, which is 52.11% down from last year.
  • As of FY2025, Aytu Biopharma's Research & Development stood at $1.3 million, which was down 52.11% from $2.8 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Research & Development ranged from a high of $12.7 million in FY2022 and a low of $1.3 million during FY2025.
  • Over the past 3 years, Aytu Biopharma's median Research & Development value was $2.8 million (recorded in 2024), while the average stood at $2.7 million.
  • Per our database at Business Quant, Aytu Biopharma's Research & Development surged by 226.54% in 2021 and then tumbled by 67.66% in 2023.
  • Yearly analysis of 5 years shows Aytu Biopharma's Research & Development stood at $5.6 million in 2021, then soared by 125.18% to $12.7 million in 2022, then slumped by 67.66% to $4.1 million in 2023, then slumped by 32.38% to $2.8 million in 2024, then tumbled by 52.11% to $1.3 million in 2025.